Home          View all 329 MoA classes  

      

Enter a class name or drug name above to search the database.

Tumor Necrosis Factor Receptor Blocking Activity [MoA] Mechanism of Action Drugs

NDC Number Brand Name Generic Name Labeler Dosage Form DEA Schedule Marketing Start Date
0069-0809 INFLECTRA infliximab-dyyb Pfizer Laboratories Div Pfizer Inc INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2016-11-21
50090-6704 HADLIMA adalimumab-bwwd A-S Medication Solutions SOLUTION 2023-07-01
50090-6705 HADLIMA adalimumab-bwwd A-S Medication Solutions SOLUTION 2023-07-01
50090-6706 HADLIMA adalimumab-bwwd A-S Medication Solutions SOLUTION 2023-07-01
50090-6707 HADLIMA adalimumab-bwwd A-S Medication Solutions SOLUTION 2023-07-01
50474-700 Cimzia certolizumab pegol UCB, Inc. KIT 2008-04-20
50474-710 Cimzia certolizumab pegol UCB, Inc. INJECTION, SOLUTION 2009-05-14
50474-750 Cimzia certolizumab pegol UCB, Inc. INJECTION, SOLUTION 2025-03-01
55513-399 AMJEVITA adalimumab-atto Amgen Inc INJECTION 2023-08-14
55513-400 AMJEVITA adalimumab-atto Amgen Inc INJECTION 2023-01-31
55513-410 AMJEVITA adalimumab-atto Amgen Inc INJECTION 2023-01-31
55513-411 AMJEVITA adalimumab-atto Amgen Inc INJECTION 2023-01-31
55513-413 AMJEVITA adalimumab-atto Amgen Inc INJECTION 2023-04-06
55513-479 AMJEVITA adalimumab-atto Amgen Inc INJECTION 2023-08-14
55513-480 AMJEVITA adalimumab-atto Amgen Inc INJECTION 2023-08-14
55513-481 AMJEVITA adalimumab-atto Amgen Inc INJECTION 2023-08-14
55513-482 AMJEVITA adalimumab-atto Amgen Inc INJECTION 2023-08-14
55513-670 AVSOLA infliximab-axxq Amgen, Inc INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2019-12-12
57894-030 REMICADE INFLIXIMAB Janssen Biotech, Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 1998-08-24
57894-070 Simponi golimumab Janssen Biotech, Inc. INJECTION, SOLUTION 2009-04-25
57894-071 Simponi golimumab Janssen Biotech, Inc. INJECTION, SOLUTION 2013-05-15
57894-160 INFLIXIMAB INFLIXIMAB Janssen Biotech, Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2021-10-05
57894-350 SIMPONI ARIA golimumab Janssen Biotech, Inc. SOLUTION 2013-07-19
58406-010 ENBREL etanercept Immunex Corporation SOLUTION 2019-06-07
58406-021 ENBREL etanercept Immunex Corporation SOLUTION 2019-06-07
58406-032 ENBREL etanercept Immunex Corporation SOLUTION 2019-06-07
58406-044 ENBREL etanercept Immunex Corporation SOLUTION 2019-06-07
58406-055 ENBREL etanercept Immunex Corporation SOLUTION 2020-03-05
61314-325 Adalimumab adalimumab-adaz Sandoz Inc INJECTION, SOLUTION 2025-01-06
61314-327 Adalimumab adalimumab-adaz Sandoz Inc INJECTION, SOLUTION 2023-07-01
61314-332 Adalimumab adalimumab-adaz Sandoz Inc INJECTION, SOLUTION 2024-12-02
61314-391 Adalimumab adalimumab-adaz Sandoz Inc INJECTION, SOLUTION 2025-03-26
61314-454 HYRIMOZ adalimumab-adaz Sandoz Inc INJECTION, SOLUTION 2023-07-01
61314-473 HYRIMOZ adalimumab-adaz Sandoz Inc INJECTION, SOLUTION 2023-07-01
61314-476 HYRIMOZ adalimumab-adaz Sandoz Inc INJECTION, SOLUTION 2023-07-01
61314-509 HYRIMOZ adalimumab-adaz Sandoz Inc INJECTION, SOLUTION 2023-07-01
61314-517 HYRIMOZ adalimumab-adaz Sandoz Inc KIT 2023-07-01
61314-531 HYRIMOZ adalimumab-adaz Sandoz Inc KIT 2023-07-01
70114-210 YUSIMRY adalimumab-aqvh Coherus BioSciences Inc INJECTION, SOLUTION 2023-07-01
70114-220 YUSIMRY adalimumab-aqvh Coherus BioSciences Inc INJECTION, SOLUTION 2023-07-01
71288-815 YUSIMRY adalimumab-aqvh Meitheal Pharmaceuticals Inc. INJECTION, SOLUTION 2023-07-01
71288-816 YUSIMRY adalimumab-aqvh Meitheal Pharmaceuticals Inc. INJECTION, SOLUTION 2023-07-01
72511-399 AMJEVITA adalimumab-atto Amgen USA Inc. INJECTION 2024-11-08
72511-400 AMJEVITA adalimumab-atto Amgen USA Inc. INJECTION 2023-01-31
72511-479 AMJEVITA adalimumab-atto Amgen USA Inc. INJECTION 2024-11-08
72511-481 AMJEVITA adalimumab-atto Amgen USA Inc. INJECTION 2023-08-14
72511-482 AMJEVITA adalimumab-atto Amgen USA Inc. INJECTION 2023-08-14
78206-162 Renflexis infliximab Organon LLC INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2017-04-21
78206-183 Hadlima adalimumab-bwwd Organon LLC SOLUTION 2023-07-01
78206-184 Hadlima adalimumab-bwwd Organon LLC SOLUTION 2023-07-01
78206-185 Hadlima adalimumab-bwwd Organon LLC SOLUTION 2023-07-01
78206-186 Hadlima adalimumab-bwwd Organon LLC SOLUTION 2023-07-01
78206-187 Hadlima adalimumab-bwwd Organon LLC SOLUTION 2023-07-01
78206-203 Adalimumab-bwwd adalimumab-bwwd Organon LLC SOLUTION 2023-06-30
78206-204 Adalimumab-bwwd adalimumab-bwwd Organon LLC SOLUTION 2023-06-30
78206-205 Adalimumab-bwwd adalimumab-bwwd Organon LLC SOLUTION 2023-06-30
78206-206 Adalimumab-bwwd adalimumab-bwwd Organon LLC SOLUTION 2023-06-30
78206-207 Adalimumab-bwwd adalimumab-bwwd Organon LLC SOLUTION 2023-06-30
83457-100 HYRIMOZ adalimumab-adaz Cordavis Limited INJECTION, SOLUTION 2023-09-21
83457-101 HYRIMOZ adalimumab-adaz Cordavis Limited INJECTION, SOLUTION 2023-09-21
83457-102 HYRIMOZ adalimumab-adaz Cordavis Limited INJECTION, SOLUTION 2023-09-21
83457-103 HYRIMOZ adalimumab-adaz Cordavis Limited INJECTION, SOLUTION 2023-09-21
83457-107 HYRIMOZ adalimumab-adaz Cordavis Limited INJECTION, SOLUTION 2023-12-15
83457-108 HYRIMOZ adalimumab-adaz Cordavis Limited INJECTION, SOLUTION 2023-12-15
83457-112 HYRIMOZ adalimumab-adaz Cordavis Limited KIT 2023-12-15
83457-113 HYRIMOZ adalimumab-adaz Cordavis Limited INJECTION, SOLUTION 2023-12-15
84612-399 AMJEVITA adalimumab-atto Optum Health Solutions (Ireland) Limited INJECTION 2025-01-01
84612-479 AMJEVITA adalimumab-atto Optum Health Solutions (Ireland) Limited INJECTION 2025-01-01
84612-481 AMJEVITA adalimumab-atto Optum Health Solutions (Ireland) Limited INJECTION 2025-01-01
84612-482 AMJEVITA adalimumab-atto Optum Health Solutions (Ireland) Limited INJECTION 2025-01-01

 Mechanism of Action Classification 

Loading full table content...